| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/22/2001 | DE19937643A1 Transgene Zellen und Pflanzen mit veränderter Aktivität des GBSSI- und des BE-Proteins Transgenic cells and plants with altered activity of the GBSSI and BE protein |
| 02/22/2001 | DE19937348A1 Nukleinsäuremoleküle aus Pflanzen codierend Enzyme, die an der Stärkesynthese beteiligt sind Nucleic acid molecules encoding enzymes from plants, which are involved in starch synthesis |
| 02/22/2001 | CA2814822A1 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and related fatty acids having a modification at the delta-9 position |
| 02/22/2001 | CA2784789A1 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides |
| 02/22/2001 | CA2733616A1 Process for the biological production of 1,3-propanediol with high titer |
| 02/22/2001 | CA2464845A1 Hematopoietic regulatory factors and methods of use thereof |
| 02/22/2001 | CA2385487A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | CA2385475A1 18 human secreted proteins |
| 02/22/2001 | CA2385431A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2383922A1 Cytokine receptor common gamma chain like |
| 02/22/2001 | CA2383691A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | CA2383264A1 Binary encoded sequence tags |
| 02/22/2001 | CA2383154A1 Baff receptor (bcma), an immunoregulatory agent |
| 02/22/2001 | CA2382655A1 Antibodies as a cancer diagnostic |
| 02/22/2001 | CA2382251A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 02/22/2001 | CA2382239A1 Screening for udp-glucose: glycoprotein glucosyltransferase (uggt) activity |
| 02/22/2001 | CA2382148A1 25 human secreted proteins |
| 02/22/2001 | CA2382103A1 Random mutagenesis and amplification of nucleic acid |
| 02/22/2001 | CA2382090A1 Coxsackie virus-derived vector system for gene transfer |
| 02/22/2001 | CA2382084A1 Phytase enzymes, nucleic acids encoding phytase enzymes and vectors and host cells incorporating same |
| 02/22/2001 | CA2382048A1 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 02/22/2001 | CA2382019A1 Isomerase proteins |
| 02/22/2001 | CA2382018A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2382015A1 Membrane associated proteins |
| 02/22/2001 | CA2381993A1 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides |
| 02/22/2001 | CA2381979A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | CA2381978A1 Ppar.delta. links apc to chemopreventive drugs |
| 02/22/2001 | CA2381927A1 Herbicide-tolerant protoporphyrinogen oxidase |
| 02/22/2001 | CA2381921A1 Means and methods for modifying gene expression using unpolyadenylated rna |
| 02/22/2001 | CA2381863A1 Novel transcription factor, bp1 |
| 02/22/2001 | CA2381794A1 Helical cytokine zalpha48 |
| 02/22/2001 | CA2381712A1 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 02/22/2001 | CA2381706A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 02/22/2001 | CA2381616A1 Alkaline xyloglucanase from malbranchea |
| 02/22/2001 | CA2381427A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| 02/22/2001 | CA2381330A1 Male sterile plants |
| 02/22/2001 | CA2381316A1 Homogentisate-dioxygenase |
| 02/22/2001 | CA2381163A1 Transgenically modified plant cells and plants having modified gbssi- and be-protein activity |
| 02/22/2001 | CA2381098A1 Polymerase extension at 3' terminus of pna-dna chimera |
| 02/22/2001 | CA2380991A1 Protective antigen of epstein barr virus |
| 02/22/2001 | CA2380948A1 Evolution and use of enzymes for combinathorial and medicinal chemistry |
| 02/22/2001 | CA2380908A1 Plasma substitute composition |
| 02/22/2001 | CA2380888A1 Treatment of metastatic disease |
| 02/22/2001 | CA2380517A1 Targeted artificial gene delivery |
| 02/22/2001 | CA2379940A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 02/22/2001 | CA2379652A1 Tryptase-like polypeptide ztryp1 |
| 02/22/2001 | CA2379431A1 Targeted lipid particles |
| 02/22/2001 | CA2379259A1 Construction of barley with decreased gel protein content |
| 02/22/2001 | CA2379196A1 Rotavirus vaccine formulations |
| 02/22/2001 | CA2379168A1 Chimeric dna/rna ribozymes containing propanediol |
| 02/22/2001 | CA2378717A1 Preparation of metal oxide supports loaded with biomolecules |
| 02/22/2001 | CA2378708A1 Method for delivery of therapeutic agents using a solution of dextrin |
| 02/22/2001 | CA2378173A1 Nucleic acid molecules derived from plants which code for enzymes which are involved in the synthesis of starch |
| 02/22/2001 | CA2377669A1 Dna shuffling of dioxygenase genes for production of industrial chemicals |
| 02/22/2001 | CA2377662A1 Novel protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 02/22/2001 | CA2372991A1 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and related fatty acids having a modification at the delta-9 position |
| 02/22/2001 | CA2346127A1 Novel deoxyribonuclease, gene encoding the same and use thereof |
| 02/21/2001 | EP1077263A1 Process for producing natural folded and secreted proteins by co-secretion of chaperones |
| 02/21/2001 | EP1077262A1 Process for the production of naturally folded and secreted proteins by co-secretion of molecular shaperones |
| 02/21/2001 | EP1077261A2 A process for the fermentative preparation of metabolic products and for the nucleotide sequences encoding sod |
| 02/21/2001 | EP1077260A1 Parvovirus NS1 variants |
| 02/21/2001 | EP1077259A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF |
| 02/21/2001 | EP1077258A1 Human hrpi |
| 02/21/2001 | EP1077257A1 Photoinhibitory promoter |
| 02/21/2001 | EP1077256A1 Novel glutaminase, gene thereof and process for producing the same |
| 02/21/2001 | EP1077255A1 Nicotianamine synthase and gene encoding the same |
| 02/21/2001 | EP1077219A1 Transcriptional regulatory factor |
| 02/21/2001 | EP1077068A1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 02/21/2001 | EP1076723A2 Use of cathepsin s in the diagnosis and treatment of endometriosis |
| 02/21/2001 | EP1076722A1 Quantitative methods, systems and apparatuses for gene expression analysis |
| 02/21/2001 | EP1076720A2 NUCLEOTIDE SEQUENCES FOR DETECTING ENTEROHEMORRHAGIC $i(ESCHERICHIA COLI) (EHEC) |
| 02/21/2001 | EP1076717A1 Recombinant baculovirus-based insecticides |
| 02/21/2001 | EP1076715A1 Novel lentiviral packaging cells |
| 02/21/2001 | EP1076714A1 Construction of retroviral producer cells from adenoviral and retroviral vectors |
| 02/21/2001 | EP1076713A1 Human bmp-7 promoter and method for exploring bone-related substance by using the same |
| 02/21/2001 | EP1076712A1 Disease resistant transgenic plants |
| 02/21/2001 | EP1076711A2 Human apoptosis associated proteins |
| 02/21/2001 | EP1076710A2 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 02/21/2001 | EP1076709A2 Sucrose phosphate synthase |
| 02/21/2001 | EP1076708A2 Method for the production of 1,3-propanediol by recombinant organisms comprising genes for vitamin b 12 transport |
| 02/21/2001 | EP1076707A1 PLASMID FOR GENE EXPRESSION IN $i(PICHIA CIFERRII) AND TRANSFORMATION METHOD USING THE SAME |
| 02/21/2001 | EP1076706A2 Methods and compositions for expression of transgenes in plants |
| 02/21/2001 | EP1076705A2 Transcription and gene expression regulators |
| 02/21/2001 | EP1076704A1 Il-2 selective agonists and antagonists |
| 02/21/2001 | EP1076703A2 Il-17 homologous polypeptides and therapeutic uses thereof |
| 02/21/2001 | EP1076702A1 Human protease associated proteins |
| 02/21/2001 | EP1076701A1 Antibodies to cd23, derivatives thereof, and their therapeutic uses |
| 02/21/2001 | EP1076700A2 Human nucleic acid sequences obtained from pancreas tumor tissue |
| 02/21/2001 | EP1076699A2 Method of inhibiting osteoclast activity |
| 02/21/2001 | EP1076698A2 Transgenic plant-derived human blood coagulation factors |
| 02/21/2001 | EP1076697A2 Semaphorin polypeptides |
| 02/21/2001 | EP1076696A2 Human receptor molecules |
| 02/21/2001 | EP1076695A1 METHODS AND COMPOSITIONS FOR SCREENING FOR MODULATORS OF IgE SYNTHESIS, SECRETION AND SWITCH REARRANGEMENT |
| 02/21/2001 | EP1076693A2 Method for increasing vitamin c content of plants |
| 02/21/2001 | EP1076692A2 Crystallizable jnk complexes |
| 02/21/2001 | EP1076691A1 Cellular and animal models for diseases associated with altered mitochondrial function |
| 02/21/2001 | EP1076690A2 Methods for modulating differentiation |
| 02/21/2001 | EP1076689A1 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
| 02/21/2001 | EP1076666A1 Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein |
| 02/21/2001 | EP1076664A2 Human bmp-4 promoter and method for exploring bone-related substance by using the same |